These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23928920)

  • 1. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks.
    Minder CM; Blumenthal RS; Blaha MJ
    Curr Opin Cardiol; 2013 Sep; 28(5):554-60. PubMed ID: 23928920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins and stroke prevention.
    Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
    Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
    Lavie G; Cohen S
    Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary prevention with statins and incident diabetes in hypertensive patients at high cardiovascular risk.
    Izzo R; de Simone G; Trimarco V; Giudice R; De Marco M; Di Renzo G; De Luca N; Trimarco B
    Nutr Metab Cardiovasc Dis; 2013 Nov; 23(11):1101-6. PubMed ID: 23419735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis.
    Savarese G; Gotto AM; Paolillo S; D'Amore C; Losco T; Musella F; Scala O; Marciano C; Ruggiero D; Marsico F; De Luca G; Trimarco B; Perrone-Filardi P
    J Am Coll Cardiol; 2013 Dec; 62(22):2090-9. PubMed ID: 23954343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
    Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
    J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin prescription in men and women at cardiovascular risk: to whom and when?
    Brugts JJ; Deckers JW
    Curr Opin Cardiol; 2010 Sep; 25(5):484-9. PubMed ID: 20625281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
    Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
    Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statins with a perspective of lifelong therapy].
    Ertaş FS
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins.
    Andrade C
    Bipolar Disord; 2013 Dec; 15(8):813-23. PubMed ID: 24119211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What do the statins tell us?
    LaRosa JC
    Am Heart J; 2002 Dec; 144(6 Suppl):S21-6. PubMed ID: 12486412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reviewing statin therapy in diabetes--towards the best practise.
    Matikainen N; Kahri J; Taskinen MR
    Prim Care Diabetes; 2010 Apr; 4(1):9-15. PubMed ID: 20171948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appropriate clinical use of statins: a discussion of the evidence, scope, benefits, and risk.
    Perlmutter D; Golomb B; Sinatra S; Campbell AW
    Altern Ther Health Med; 2013; 19 Suppl 1():14-25. PubMed ID: 23981463
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence-based use of statins for primary prevention of cardiovascular disease.
    Minder CM; Blaha MJ; Horne A; Michos ED; Kaul S; Blumenthal RS
    Am J Med; 2012 May; 125(5):440-6. PubMed ID: 22387091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.